Scope of the Study
A growing number of research grants and projects by various research organizations will help to boost global exosomes market in the forecasted period. Exosomes play a significant role in facilitating cell-to-cell communication in the cancer prognosis. It helps to suppress the immune function by inducing apoptosis of activated cytotoxic T cells, which allow tumor progression in the human body. Also, exosomes stimulate the angiogenesis and migration leading to metastasis. In Addition, it triggers apoptosis in anti-tumor immune cells through tumor necrosis factor pathways. Increasing occurrence of cancer, technological advancements in exosomes isolation and analytical procedures are the key drivers of global exosomes market.
The market study is being classified, by Application (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases and Others) and major geographies with country level break-up. According to AMA, the Global Exosomes market is expected to see growth rate of 16.8%
Fujifilm (Japan), Thermo Fisher Scientific, Inc. (United States), Danaher (United States), Lonza (Switzerland), Illumina, Inc. (United States), Qiagen (Germany), Takara Bio Company (Japan), Malvern Instruments Ltd. (United Kingdom), Miltenyi Biotec (Germany) and Aethlon Medical, Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Exosome Diagnostics Inc. (United States), NanoSomix Inc. (United States) and System Biosciences Inc. (United States).
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Exosomes market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Exosomes market by Type, Application and Region.
On the basis of geography, the market of Exosomes has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2018. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. If we see Market by Downstream Analysis, the sub-segment i.e. Cell Surface Marker Analysis using Flow Cytometry will boost the Exosomes market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Isolation Methods , the sub-segment i.e. Ultracentrifugation will boost the Exosomes market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Biomolecule Type, the sub-segment i.e. Non-coding RNAs will boost the Exosomes market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- High Global Prevalence of Cancer
- Increasing Interest in Exosome-Based Procedures
- Rising Expenditure for Life Science Research and Developments
- Growing Number of Advanced Applications of Exosomes
- Dearth of Skilled Professionals
- High Adoption in Untapped Emerging Countries
- Huge Opportunity Due to Personalized Medicine
- Stringent Regulatory Necessities for the Approval As Well As Commercialization of Exosomes
Market Leaders and their expansionary development strategies
On 13th July 2018, Exosomics Siena S.p.A., a pioneer and world leader in exosome-based diagnostics have launched of its first proprietary liquid biopsy solutions, SeleCTEV™ DNA and SortEV™ RNA, for the selective isolation of tumor-derived nucleic acids from complex biofluids such as plasma or serum.
On 25th June 2018, Bio-Techne Corporation has acquired Exosome Diagnostics, Inc. the deal was established for 250 million dollars in cash plus contingent consideration of up to 325 million dollars due upon the achievement of certain future milestones.
Key Target AudienceMedical Institutes, Industry Association Related to Exosomes, Government Regulatory Bodies, Government and Private Research Organization and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase